SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000947
Filing Date
2022-04-15
Accepted
2022-04-15 16:16:43
Documents
89
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scps-20211231x10k.htm   iXBRL 10-K 1820905
2 EX-21.1 scps-20211231xex21d1.htm EX-21.1 3989
3 EX-23.1 scps-20211231xex23d1.htm EX-23.1 3574
4 EX-23.2 scps-20211231xex23d2.htm EX-23.2 3765
5 EX-31.1 scps-20211231xex31d1.htm EX-31.1 14464
6 EX-31.2 scps-20211231xex31d2.htm EX-31.2 14619
7 EX-32.1 scps-20211231xex32d1.htm EX-32.1 7239
8 EX-32.2 scps-20211231xex32d2.htm EX-32.2 7265
9 GRAPHIC scps-20211231x10k003.jpg GRAPHIC 16273
10 GRAPHIC scps-20211231x10k001.jpg GRAPHIC 5127
11 GRAPHIC scps-20211231x10k002.jpg GRAPHIC 16367
12 GRAPHIC scps-20211231x10k004.jpg GRAPHIC 17053
  Complete submission text file 0001410578-22-000947.txt   7393826

Data Files

Seq Description Document Type Size
13 EX-101.SCH scps-20211231.xsd EX-101.SCH 70298
14 EX-101.CAL scps-20211231_cal.xml EX-101.CAL 48408
15 EX-101.DEF scps-20211231_def.xml EX-101.DEF 244761
16 EX-101.LAB scps-20211231_lab.xml EX-101.LAB 536165
17 EX-101.PRE scps-20211231_pre.xml EX-101.PRE 437831
83 EXTRACTED XBRL INSTANCE DOCUMENT scps-20211231x10k_htm.xml XML 927125
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39788 | Film No.: 22830204
SIC: 2834 Pharmaceutical Preparations